← Back to headlines
Bio-Techne Stock Surges on Merck KGaA Acquisition Offer
Bio-Techne's stock experienced a significant surge after Merck KGaA announced a cash acquisition offer of $73 per share, signaling a major development in the biotechnology sector.
25 Jun, 21:43 — 25 Jun, 21:43
Sources
Showing 1 of 1 sources



